{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:37:57Z","timestamp":1787161077788,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.cyto.2024.156790","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T17:18:01Z","timestamp":1729876681000},"page":"156790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Complement factor H-related protein 5 alleviates joint inflammation and osteoclast differentiation by disrupting RANK-JNK signaling in collagen antibody-induced arthritis mouse model"],"prefix":"10.1016","volume":"184","author":[{"given":"Chanhyeok","family":"Jeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Me","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hyon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Seo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Mo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungsin","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6855-7921","authenticated-orcid":false,"given":"Tae-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Nam","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10055","key":"10.1016\/j.cyto.2024.156790_b0005","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"issue":"9164","key":"10.1016\/j.cyto.2024.156790_b0010","first-page":"1568","article-title":"Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial","volume":"353","author":"Mottonen","year":"1999","journal-title":"FIN-RACo Trial Group, Lancet"},{"issue":"6","key":"10.1016\/j.cyto.2024.156790_b0015","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/ard.2009.126532","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.cyto.2024.156790_b0020","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"issue":"5\u20136","key":"10.1016\/j.cyto.2024.156790_b0025","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1159\/000491439","article-title":"Complement and Bacterial Infections: From Molecular Mechanisms to Therapeutic Applications","volume":"10","author":"Heesterbeek","year":"2018","journal-title":"J Innate Immun"},{"issue":"4","key":"10.1016\/j.cyto.2024.156790_b0030","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cll.2019.07.006","article-title":"Analysis of the Complement System in the Clinical Immunology Laboratory","volume":"39","author":"Ling","year":"2019","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.cyto.2024.156790_b0035","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3389\/fimmu.2018.01057","article-title":"Complement in the Initiation and Evolution of Rheumatoid Arthritis","volume":"9","author":"Holers","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2024.156790_b0040","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res"},{"issue":"3","key":"10.1016\/j.cyto.2024.156790_b0045","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.4049\/jimmunol.177.3.1904","article-title":"Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis","volume":"177","author":"Banda","year":"2006","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.cyto.2024.156790_b0050","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.4049\/jimmunol.179.6.4101","article-title":"Pathogenic complement activation in collagen antibody-induced arthritis in mice requires amplification by the alternative pathway","volume":"179","author":"Banda","year":"2007","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.cyto.2024.156790_b0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1074-7613(02)00275-3","article-title":"Arthritis critically dependent on innate immune system players","volume":"16","author":"Ji","year":"2002","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.cyto.2024.156790_b0060","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.4049\/jimmunol.1102310","article-title":"Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice","volume":"188","author":"Banda","year":"2012","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.cyto.2024.156790_b0065","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.4049\/jimmunol.0901826","article-title":"Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice","volume":"183","author":"Banda","year":"2009","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.cyto.2024.156790_b0070","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.4049\/jimmunol.1403012","article-title":"A New Approach for the Treatment of Arthritis in Mice with a Novel Conjugate of an Anti-C5aR1 Antibody and C5 Small Interfering RNA","volume":"194","author":"Mehta","year":"2015","journal-title":"J Immunol"},{"issue":"19","key":"10.1016\/j.cyto.2024.156790_b0075","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1073\/pnas.92.19.8955","article-title":"Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease","volume":"92","author":"Wang","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.cyto.2024.156790_b0080","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1084\/jem.20070432","article-title":"A novel inhibitor of the alternative pathway of complement reverses inflammation and bone destruction in experimental arthritis","volume":"204","author":"Katschke","year":"2007","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.cyto.2024.156790_b0085","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1002\/art.34430","article-title":"Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5","volume":"64","author":"Macor","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.cyto.2024.156790_b0090","doi-asserted-by":"crossref","first-page":"e58696","DOI":"10.1371\/journal.pone.0058696","article-title":"Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5","volume":"8","author":"Durigutto","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cyto.2024.156790_b0095","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/art.21729","article-title":"Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q\u2013C4 complexes as novel activation products","volume":"54","author":"Wouters","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.cyto.2024.156790_b0100","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/ard.2004.029124","article-title":"Infliximab treatment reduces complement activation in patients with rheumatoid arthritis","volume":"64","author":"Familian","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.cyto.2024.156790_b0105","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1002\/art.23989","article-title":"Analysis of apoptosis in peripheral blood and synovial tissue very early after initiation of infliximab treatment in rheumatoid arthritis patients","volume":"58","author":"Wijbrandts","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2024.156790_b0110","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement System Part I - Molecular Mechanisms of Activation and Regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2024.156790_b0115","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4049\/jimmunol.1600483","article-title":"FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation","volume":"199","author":"Csincsi","year":"2017","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.cyto.2024.156790_b0120","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.4049\/jimmunol.174.10.6250","article-title":"Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein","volume":"174","author":"McRae","year":"2005","journal-title":"J Immunol"},{"issue":"9743","key":"10.1016\/j.cyto.2024.156790_b0125","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0140-6736(10)60670-8","article-title":"Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis","volume":"376","author":"Gale","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2024.156790_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.676662","article-title":"Selective Binding of Heparin\/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies","volume":"12","author":"Loeven","year":"2021","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.cyto.2024.156790_b0135","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.molimm.2006.08.004","article-title":"Genetic analysis of the complement factor H related 5 gene in haemolytic uraemic syndrome","volume":"44","author":"Monteferrante","year":"2007","journal-title":"Mol Immunol"},{"issue":"8","key":"10.1016\/j.cyto.2024.156790_b0140","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.it.2008.04.008","article-title":"Factor H family proteins and human diseases","volume":"29","author":"Jozsi","year":"2008","journal-title":"Trends Immunol"},{"issue":"5","key":"10.1016\/j.cyto.2024.156790_b0145","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1681\/ASN.2005010078","article-title":"Membranoproliferative glomerulonephritis type II (dense deposit disease): an update","volume":"16","author":"Appel","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.cyto.2024.156790_b0150","doi-asserted-by":"crossref","first-page":"7752","DOI":"10.1038\/s41467-023-43764-4","article-title":"Author Correction: Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism","volume":"14","author":"Iglesias","year":"2023","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.cyto.2024.156790_b0155","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nprot.2007.173","article-title":"Collagen-induced arthritis","volume":"2","author":"Brand","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.cyto.2024.156790_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122894","article-title":"Swimming exercise alleviates pathological bone features in curdlan-injected SKG mice by inducing irisin expression","volume":"352","author":"Lee","year":"2024","journal-title":"Life Sci"},{"issue":"5","key":"10.1016\/j.cyto.2024.156790_b0165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1078\/0344-0338-5710261","article-title":"Grading of chronic synovitis\u2013a histopathological grading system for molecular and diagnostic pathology","volume":"198","author":"Krenn","year":"2002","journal-title":"Pathol Res Pract"},{"issue":"3","key":"10.1016\/j.cyto.2024.156790_b0170","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/art.10850","article-title":"Placental immunomodulator ferritin, a novel immunoregulator, suppresses experimental arthritis","volume":"48","author":"Weinberger","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.cyto.2024.156790_b0175","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/annrheumdis-2020-219247","article-title":"'SMASH' recommendations for standardised microscopic arthritis scoring of histological sections from inflammatory arthritis animal models","volume":"80","author":"Hayer","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.cyto.2024.156790_b0180","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/jbmr.4751","article-title":"Platelet-Derived Growth Factor B Is a Key Element in the Pathological Bone Formation of Ankylosing Spondylitis","volume":"38","author":"Jo","year":"2023","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cyto.2024.156790_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122204","article-title":"Myosin heavy chain 2 (MYH2) expression in hypertrophic chondrocytes of soft callus provokes endochondral bone formation in fracture","volume":"334","author":"Jo","year":"2023","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.cyto.2024.156790_b0190","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4078\/jrd.2023.0024","article-title":"Elevated BMPR2 expression amplifies osteoblast differentiation in ankylosing spondylitis","volume":"30","author":"Jo","year":"2023","journal-title":"J Rheum Dis"},{"key":"10.1016\/j.cyto.2024.156790_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110132","article-title":"Abnormal kynurenine level contributes to the pathological bone features of ankylosing spondylitis","volume":"118","author":"Jeon","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"10.1016\/j.cyto.2024.156790_b0200","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00109-024-02428-6","article-title":"The complement factor H-related protein-5 (CFHR5) exacerbates pathological bone formation in ankylosing spondylitis","volume":"102","author":"Lee","year":"2024","journal-title":"J Mol Med (berl)"},{"issue":"1","key":"10.1016\/j.cyto.2024.156790_b0205","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1038\/s41467-023-38383-y","article-title":"Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism","volume":"14","author":"Iglesias","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.cyto.2024.156790_b0210","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/ajkd.2002.29873","article-title":"Factor H-related protein-5: a novel component of human glomerular immune deposits","volume":"39","author":"Murphy","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.cyto.2024.156790_b0215","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1186\/s12967-023-04730-2","article-title":"Complement factor H attenuates TNF-alpha-induced inflammation by upregulating EIF3C in rheumatoid arthritis","volume":"21","author":"Jia","year":"2023","journal-title":"J Transl Med"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624002941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624002941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T18:29:32Z","timestamp":1731954572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466624002941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":43,"alternative-id":["S1043466624002941"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156790","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement factor H-related protein 5 alleviates joint inflammation and osteoclast differentiation by disrupting RANK-JNK signaling in collagen antibody-induced arthritis mouse model","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156790","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156790"}}